Ormus
On the Bulgarian pack: Ормус 40 mg прах за инжекционен/ инфузионен разтвор
40 mg · powder for solution for injection/infusion
- Prescription only
- Digestion, stomach, diabetes and nutrition
- Active substance
- Esomeprazole
- Made by
- Stada Arzneimittel AG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet read the official leaflet for this product. The exact uses and dose are in the leaflet inside the pack. Open the official leaflet
How it works
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (esomeprazole magnesium). It describes the substance, not this Bulgarian product — its uses and doses can differ.
Esomeprazole belongs to a class of antisecretory compounds, the substituted benzimidazoles, that suppress gastric acid secretion by specific inhibition of the H+/K+ ATPase enzyme system at the secretory surface of the gastric parietal cell.
Esomeprazole is protonated and converted in the acidic compartment of the parietal cell forming the active inhibitor, the achiral sulphenamide.
Esomeprazole is extensively metabolized in the liver by the cytochrome P450 (CYP) enzyme system.
Less than 1% of parent drug is excreted in the urine.
The AUC after administration of a single 40 mg dose of esomeprazole magnesium delayed-release capsules is decreased by 43% to 53% after food intake compared to fasting conditions [see Dosage and Administration ( 2.3 )].
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-01-20
Safety of the active substance
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (esomeprazole magnesium). It describes the substance, not this Bulgarian product — its uses and doses can differ.
- Esomeprazole magnesium delayed-release capsules are contraindicated in patients with known hypersensitivity to substituted benzimidazoles or to any component of the formulation.
- Hypersensitivity reactions may include anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute tubulointerstitial nephritis, and urticaria [see Warnings and Precautions ( 5.2 ), Adverse Reactions ( 6.2 ) ].
- For information about contraindications of amoxicillin and clarithromycin, indicated in combination with esomeprazole magnesium delayed-release capsules for H. pylori eradication to reduce the risk of duodenal ulcer recurrence, refer to the Contraindications section of the respective prescribing information.
- Proton pump inhibitors (PPIs), including esomeprazole magnesium, are contraindicated in patients receiving rilpivirine-containing products [see Drug Interactions ( 7 ) ]. · Known hypersensitivity to substituted benzimidazoles or any component of the formulation.
The most frequently occurring adverse reactions (at least 1%) in all three groups were headache (5.5%, 5%, and 3.8%, respectively) and diarrhea (no difference among the three groups).
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States1 matching products
European UnionNo exact match for this strength and form
Spain4 matching products
CanadaNo exact match for this strength and form
Netherlands10 matching products
- Esomeprazol Accord 40 mg poeder voor oplossing voor injectie / infusie 40 mg · poeder voor oplossing voor injectie of infusie
- Esomeprazol ADOH 40 mg 40 mg · poeder voor oplossing voor injectie of infusie
- Esomeprazol CF i.v. 40 mg 40 mg · poeder voor oplossing voor injectie of infusie
- Esomeprazol DEMO 40 mg poeder voor oplossing voor injectie/infusie 40 mg · poeder voor oplossing voor injectie of infusie
- Esomeprazol Pharmathen 40mg poeder voor oplossing voor injectie en intraveneuze infusie 40mg · poeder voor oplossing voor injectie of infusie
- Esomeprazol SUN 40 mg poeder voor oplossing voor injectie en intraveneuze infusie 40 mg · poeder voor oplossing voor injectie of infusie
- Esomeprazol SUN Pharma 40 mg 40 mg · poeder voor oplossing voor injectie of infusie
- Esomeprazol Tillomed 40 mg poeder voor oplossing voor injectie/infusie 40 mg · poeder voor oplossing voor injectie of infusie
SwitzerlandNo exact match for this strength and form
Details
| Made by | Stada Arzneimittel AG · Germany |
|---|---|
| Active substance | Esomeprazole |
| Used in | Digestion, stomach, diabetes and nutrition |
| Strength | 40 mg |
| Form | powder for solution for injection/infusion |
| Pack sizes | 1 · 10 |
| Classification | A02BC05 · Digestion, stomach, diabetes and nutrition |
| Name in the register | Ормус 40 mg прах за инжекционен/ инфузионен разтвор |
| Reg. no. | 20140017 |
Source: Bulgarian Drug Agency register · 2026-08-01 · not reviewed by a clinician
Източник: Изпълнителна агенция по лекарствата (ИАЛ). The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.
Other strengths and forms
3 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- gastro-resistant capsule, hard2 products
- powder for solution for injection/infusion1 products
- 40 mg
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.